Remedor Biomed

We are a company that revolutionizes complex wound treatment exclusively via our patented technology. We are Remedor, a highly focused wound healing clinical research stage biopharmaceutical company. We are proud of who we are, what we do, and how we do it. Our mission is to introduce an innovative, high-quality topical drug technology to improve complex wound healing and impact patient's health and quality of life. But we are doing more than developing a technology that performs well in the clinic, we are elevating the current standard of care to bring greater benefits to patients with complex wounds such as diabetic foot ulcer and deep burn wounds. Belokopytov joined Remedor in 2015 and is responsible for the research and clinical affairs of the company. Richardson started managing Remedor’s business activities in 2018. We believe it is urgent to provide an immediate pharmaceutical solution for the diabetic foot problem.